16-3050360-G-A

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_022468.5(MMP25):​c.475G>A​(p.Glu159Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

MMP25
NM_022468.5 missense

Scores

2
7
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.01
Variant links:
Genes affected
MMP25 (HGNC:14246): (matrix metallopeptidase 25) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily, attached to the plasma membrane via a glycosylphosphatidyl inositol anchor. In response to bacterial infection or inflammation, the encoded protein is thought to inactivate alpha-1 proteinase inhibitor, a major tissue protectant against proteolytic enzymes released by activated neutrophils, facilitating the transendothelial migration of neutrophils to inflammatory sites. The encoded protein may also play a role in tumor invasion and metastasis through activation of MMP2. The gene has previously been referred to as MMP20 but has been renamed MMP25. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.942

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MMP25NM_022468.5 linkuse as main transcriptc.475G>A p.Glu159Lys missense_variant 4/10 ENST00000336577.9 NP_071913.1 Q9NPA2
MMP25XM_024450391.2 linkuse as main transcriptc.373G>A p.Glu125Lys missense_variant 3/9 XP_024306159.1
MMP25XM_017023561.2 linkuse as main transcriptc.475G>A p.Glu159Lys missense_variant 4/6 XP_016879050.1
MMP25XM_024450390.2 linkuse as main transcriptc.232+2813G>A intron_variant XP_024306158.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MMP25ENST00000336577.9 linkuse as main transcriptc.475G>A p.Glu159Lys missense_variant 4/101 NM_022468.5 ENSP00000337816.4 Q9NPA2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 29, 2024The c.475G>A (p.E159K) alteration is located in exon 4 (coding exon 4) of the MMP25 gene. This alteration results from a G to A substitution at nucleotide position 475, causing the glutamic acid (E) at amino acid position 159 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.021
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.26
.;T
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.68
T;T
M_CAP
Benign
0.085
D
MetaRNN
Pathogenic
0.94
D;D
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
2.0
.;M
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-3.2
.;D
REVEL
Benign
0.27
Sift
Uncertain
0.020
.;D
Sift4G
Benign
0.28
T;T
Polyphen
0.94
P;D
Vest4
0.70
MutPred
0.69
.;Gain of methylation at E159 (P = 0.0121);
MVP
0.71
MPC
0.69
ClinPred
0.97
D
GERP RS
5.0
Varity_R
0.43
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr16-3100361; API